| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.3M | -58.6% |
| R&D Expense | $199.2M | +12.2% |
| SG&A Expense | $72.0M | +3.4% |
| Operating Income | -$251.2M | -48.5% |
| Interest Expense | $2.1M | — |
| Income Tax | $0 | — |
| Net Income | -$237.1M | -54.7% |
| EPS (Basic) | -$2.88 | -42.6% |
| EPS (Diluted) | -$2.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $131.5M | +6.4% |
| Short-term Investments | $138.4M | -30.6% |
| Accounts Receivable | $16.3M | +59.7% |
| Current Assets | $289.3M | -15.1% |
| Total Assets | $341.6M | -31.6% |
| Current Liabilities | $77.2M | +22.2% |
| Long-term Debt | $57.4M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$210.3M | -59.1% |
| Capital Expenditures | $8.8M | +87.0% |
| Investing Cash Flow | $162.1M | +4445.9% |
| Financing Cash Flow | $56.0M | -52.5% |
| Free Cash Flow | -$219.1M | -60.1% |
| -42.6% |
| Total Liabilities |
| $207.3M |
| +38.2% |
| Stockholders' Equity | $134.3M | -61.5% |